174 related articles for article (PubMed ID: 24879377)
1. BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.
Mei P; Bai J; Shi M; Liu Q; Li Z; Fan Y; Zheng J
PLoS One; 2014; 9(5):e98544. PubMed ID: 24879377
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
3. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
Al-Alwan M; Olabi S; Ghebeh H; Barhoush E; Tulbah A; Al-Tweigeri T; Ajarim D; Adra C
PLoS One; 2011; 6(11):e27339. PubMed ID: 22076152
[TBL] [Abstract][Full Text] [Related]
4. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases.
Kodura MA; Souchelnytskyi S
Cancer Metastasis Rev; 2015 Dec; 34(4):611-8. PubMed ID: 26328523
[TBL] [Abstract][Full Text] [Related]
6. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
Sheng XJ; Zhou YQ; Song QY; Zhou DM; Liu QC
Oncol Rep; 2012 Apr; 27(4):1011-8. PubMed ID: 22200669
[TBL] [Abstract][Full Text] [Related]
7. Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.
Miao F; Cui C; Zuo D; Zhang H; Mei P; Chen H; Wei S; Yang F; Zheng J; Bai J; Fan Y
J Neurooncol; 2019 Jun; 143(2):221-229. PubMed ID: 30997639
[TBL] [Abstract][Full Text] [Related]
8. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
10. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
11. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
Smith PW; Liu Y; Siefert SA; Moskaluk CA; Petroni GR; Jones DR
Cancer Lett; 2009 Apr; 276(2):196-203. PubMed ID: 19111386
[TBL] [Abstract][Full Text] [Related]
15. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma.
Mei PJ; Bai J; Miao FA; Li ZL; Chen C; Zheng JN; Fan YC
Invest New Drugs; 2019 Aug; 37(4):646-657. PubMed ID: 30328556
[TBL] [Abstract][Full Text] [Related]
16. miR-142 inhibits the migration and invasion of glioma by targeting Rac1.
Qin W; Rong X; Dong J; Yu C; Yang J
Oncol Rep; 2017 Sep; 38(3):1543-1550. PubMed ID: 28714015
[TBL] [Abstract][Full Text] [Related]
17. Role of metallothionein 1E in the migration and invasion of human glioma cell lines.
Ryu HH; Jung S; Jung TY; Moon KS; Kim IY; Jeong YI; Jin SG; Pei J; Wen M; Jang WY
Int J Oncol; 2012 Oct; 41(4):1305-13. PubMed ID: 22843066
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
[TBL] [Abstract][Full Text] [Related]
19. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
[TBL] [Abstract][Full Text] [Related]
20. Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma.
Babu D; Chintal R; Panigrahi M; Phanithi PB
Cell Oncol (Dordr); 2022 Dec; 45(6):1451-1465. PubMed ID: 36284039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
